NDC 67457-263
chlorothiazide sodium
Chlorothiazide Sodium
chlorothiazide sodium is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Mylan Institutional Llc. The primary component is Chlorothiazide Sodium.
| Product ID | 67457-263_2e00b397-3ffb-4009-9197-00596e65a59e |
| NDC | 67457-263 |
| Product Type | Human Prescription Drug |
| Proprietary Name | chlorothiazide sodium |
| Generic Name | Chlorothiazide Sodium |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2014-08-08 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA202493 |
| Labeler Name | Mylan Institutional LLC |
| Substance Name | CHLOROTHIAZIDE SODIUM |
| Active Ingredient Strength | 500 mg/18mL |
| Pharm Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |